Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Nevronas AB
AB
Active
Org 5594295080
Humlegårdsvägen 19 Lgh 1001
Hospital activities · NACE 8610
Est. 2023
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 1,5M
-6% vs 2024
EBITDA margin
2.7%
-91% vs 2024
Equity ratio
37.2%
Financial strength
Net profit 2025
SEK 24K
-91% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 1,5M
-6%
EBITDA
SEK 41K
-91%
Net profit
SEK 24K
-91%
Total assets
SEK 862K
-5%
Equity
SEK 321K
+8%
Employees
1
—
Company information
Legal name
Nevronas AB
Org number
5594295080
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
5 april 2023
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva läkarkonsultativ verksamhet och uthyrning av läkartjänster samt därmed förenlig verksamhet.
Contact
Address
Humlegårdsvägen 19 Lgh 1001
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Hospital activities
Companies in Gotland
All Sweden companies
Revenue
SEK millions
0M
1M
1M
2M
2M
2M
2024
2M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
Income statement
SEK thousands
Item
2024
2025
Revenue
1 635
1 536
Staff expenses
—
—
EBITDA
456
41
Depreciation & amort.
−0
−0
EBIT
456
41
Net financials
—
1
Profit before tax
343
31
Tax
−71
−7
Net profit
272
24
Balance sheet
SEK thousands
Item
2024
2025
Total assets
903
862
Equity
297
321
Long-term debt
0
0
Short-term debt
493
417
Total debt
493
417
Financial ratios
5-year trend
EBITDA margin
2.7%
This company
15.8%
Market median
-83% vs market
2024
2025
Equity ratio
37.2%
This company
38.2%
Market median
+3% vs market
2024
2025
Return on equity
7.5%
This company
18.4%
Market median
-59% vs market
2024
2025
Net profit margin
1.6%
This company
8.1%
Market median
-80% vs market
2024
2025
Asset turnover
1.78×
This company
1.12×
Market median
+59% vs market
2024
2025
Debt / equity
1.69×
This company
0.62×
Market median
-173% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-08-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
MS
Michail Safarikas
Board of Directors
2023
VK
Vasileios Kanellos
Deputy Board Member
2023
Former (3)
MH
M H Charlotte Wiberg Larsson
Board of Directors
2023 – 2023
PJ
Peter Jonas Michael Carlborg
Deputy Board Member
2023 – 2023
BT
Bo Torsten Patrik Nilsson
Deputy Board Member
2023 – 2023
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Nevronas AB also hold positions in
0
other companies.
Person
Role here
Other companies
Michail Safarikas
Board of Directors
0 companies
M H Charlotte Wiberg Larsson
Board of Directors
0 companies
Vasileios Kanellos
Deputy Board Member
0 companies
Peter Jonas Michael Carlborg
Deputy Board Member
0 companies
Bo Torsten Patrik Nilsson
Deputy Board Member
0 companies